Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD).

Jiménez-González C, Iruzubieta P, Alonso-Peña M, Cayón L, Crespo J

Open source

DOI
10.3389/fphar.2026.1884657
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1884657,
  title = {Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD).},
  author = {Jiménez-González C and Iruzubieta P and Alonso-Peña M and Cayón L and Crespo J},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1884657},
  url = {https://doi.org/10.3389/fphar.2026.1884657}
}

RIS

TY  - JOUR
TI  - Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD).
AU  - Jiménez-González C
AU  - Iruzubieta P
AU  - Alonso-Peña M
AU  - Cayón L
AU  - Crespo J
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1884657
UR  - https://doi.org/10.3389/fphar.2026.1884657
ER  - 

APA

C, J., P, I., M, A., L, C., & J, C. (2026). Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD).. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1884657

Source records